LIQUID FORMULATION PHARMACEUTICAL COMPOSITION COMPRISING PLASMID DNA
The present invention relates to a liquid formulation pharmaceutical composition comprising plasmid DNA. The liquid formulation comprising plasmid DNA according to the present invention shows excellent efficacy in terms of storage stability of plasmid DNA, which is a pharmaceutically active ingredie...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French Korean |
Published |
28.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a liquid formulation pharmaceutical composition comprising plasmid DNA. The liquid formulation comprising plasmid DNA according to the present invention shows excellent efficacy in terms of storage stability of plasmid DNA, which is a pharmaceutically active ingredient, and accordingly, can be useful as a pharmaceutical composition with excellent product stability and safety.
La présente invention concerne une composition pharmaceutique de formulation liquide comprenant de l'ADN plasmidique. La formulation liquide comprenant de l'ADN plasmidique selon la présente invention présente une excellente efficacité en termes de stabilité de stockage de l'ADN plasmidique, qui est un principe pharmaceutiquement actif, et par conséquent, peut être utile en tant que composition pharmaceutique ayant une excellente stabilité et une sûreté du produit.
본 발명은 플라스미드 DNA를 포함하는 액체제형 약제학적 조성물에 관한 것이다. 본 발명에 따른 플라스미드 DNA를 포함하는 액체 제형은, 약제학적 유효성분인 플라스미드 DNA의 보관안정성의 면에서 우수한 효능을 나타내는 바, 제품의 안정성 및 안전성이 우수한 약제학적 조성물로 유용하게 사용될 수 있다. |
---|---|
Bibliography: | Application Number: WO2022KR19410 |